Mergers and acquisitions
Digital Diagnostics, formerly IDx, is looking to expand into the skin health space with this new purchase.
The patient-facing EASE app is HIPAA compliant, and does not save any texts, photos or videos to the recipient's device.
After news broke about the $18.5 million deal all eyes in the digital health world have been on Livongo and Teladoc.
The company's smart insulin pen, dubbed the InPen, is slated to become part of Medtronics diabetes portfolio.
The MobiHealthNews team breaks down the week's big digital health news: Teladoc's proposed $18 billion acquisition of Livongo.
The deal is valued at roughly $4.7 billion.
Each Livongo share will be converted Teladoc stock at a 0.5920 exchange rate, plus an additional $11.44 in cash per stock.
WhiteHatAI's technology can help address false claims, waste, abuse and fraud in the system.
Arkos Health will weave together Curavi Health, CarePointe and U.S. Health Systems' various care platforms for payer and provider customers.
Although most deals are undisclosed and some are partial asset acquisitions, the numbers undeniably show a busy year for the space.